Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-06

Clinical Trial Update: Evaluation of the Effect of a Toothpaste Containing 0.3% Chlorhexidine in Subjects With Established Dental Plaque and Gingivitis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a toothpaste containing 0.3% chlorhexidine for dental plaque and gingivitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine toothpaste 0.3% (Chlorhexidine)

Snippet

Sponsor: Colgate Palmolive | Conditions: Gingivitis, Gingivitis and Periodontal Diseases | Phase 3 | Status: COMPLETED